Zhengye Biotechnology Holding (ZYBT) Receivables - Other (2023 - 2025)
Zhengye Biotechnology Holding (ZYBT) posted quarterly Receivables - Other of $104052.5 for Q4 2025, up 1.28% year-over-year from $102741.2 in Q4 2024, and up 110.65% quarter-over-quarter from -$977000.0 in Q2 2025.
Zhengye Biotechnology Holding (ZYBT) Receivables - Other (2023 - 2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has reported Receivables - Other for 3 consecutive years, with $104052.5 the latest figure, recorded in Q4 2025.
- In Q4 2025, Receivables - Other rose 1.28% year-over-year to $104052.5; the TTM figure through Dec 2025 stood at $104052.5 (up 1.28% YoY), while the FY2025 annual figure was $3.3 million, up 829.17% from the prior year.
- Receivables - Other grew to $104052.5 in Q4 2025 per ZYBT's latest filing, from -$977000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $180831.4 in Q4 2023 and bottomed at -$977000.0 in Q2 2025.
- Historically, Receivables - Other has averaged -$147343.7 across 3 years, with a median of $103396.9 in 2024.
- Annual changes were most pronounced in 2024 — Receivables - Other sank 43.18% — and 2025, when it advanced 1.28%.
- Zhengye Biotechnology Holding's Receivables - Other stood at $180831.4 in 2023, then tumbled by 43.18% to $102741.2 in 2024, then gained by 1.28% to $104052.5 in 2025.
- Business Quant data shows ZYBT's Receivables - Other at $104052.5 in Q4 2025, -$977000.0 in Q2 2025, and $102741.2 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Zhengye Biotechnology Holding | 88.82 Mn | 81.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 104,052.54 |
| Dec 31, 2025 | 104,052.54 |
| Jun 30, 2025 | -977,000.00 |
| Jun 30, 2025 | -977,000.00 |
| Dec 31, 2024 | 102,741.20 |
| Dec 31, 2024 | 102,741.20 |
| Dec 31, 2023 | 180,831.39 |
| Dec 31, 2023 | 180,831.39 |